AchillesLatest News

Achilles Therapeutics doses first patient in Phase I/II Study in recurrent or metastatic malignant melanoma with first TIL therapy to specifically target clonal neoantigens

29/05/2020

Stevenage, UK 29 May 2020 – Achilles Therapeutics (“Achilles”), a clinical stage biopharmaceutical company developing personalised cancer immunotherapies, today announced that...

Read More +

Achilles Therapeutics to present at Jefferies Virtual Healthcare Conference

28/05/2020

Stevenage, UK 28 May, 2020 – Achilles Therapeutics (“Achilles”), a clinical-stage oncology company developing personalised cell therapies targeting clonal neoantigens, a novel...

Read More +

Achilles Therapeutics announces formation of Scientific Advisory Board

13/05/2020

– World-leading experts in oncology, immunology and R&D will advise the Company as it advances pipeline of pioneering cancer therapies –...

Read More +

Achilles Therapeutics to present a manufacturing update at the virtual 2020 AACR Annual Meeting

22/04/2020

Stevenage, UK 22 April, 2020 – Achilles Therapeutics (“Achilles”), a clinical-stage oncology company developing personalised cell therapies targeting clonal neoantigens, a novel...

Read More +

Achilles Therapeutics appoints Carsten Boess to the Board of Directors

07/04/2020

Stevenage, UK 7 April, 2020 – Achilles Therapeutics (“Achilles”), a clinical-stage oncology company developing personalised cell therapies targeting clonal neoantigens, a novel...

Read More +

Achilles Therapeutics appoints Professor Sergio Quezada as Chief Scientific Officer

17/03/2020

– Professor Quezada is an internationally recognized leader in the field of cancer immunology and a founder of the company –...

Read More +

Achilles Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference

07/01/2020

Stevenage, UK 7 January 2020 – Achilles Therapeutics (“Achilles”), a biopharmaceutical company developing personalised cancer immunotherapies, today announced that Dr. Iraj...

Read More +

Achilles Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference

28/11/2019

Stevenage, UK 28 November 2019 – Achilles Therapeutics (“Achilles”), a biopharmaceutical company developing personalised cancer immunotherapies, today announced that Dr. Iraj Ali,...

Read More +

Achilles Therapeutics to Present at the Jefferies 2019 London Healthcare Conference

14/11/2019

Stevenage, UK 14 November 2019 – Achilles Therapeutics (“Achilles”), a biopharmaceutical company developing personalised cancer immunotherapies, today announced that Dr. Iraj...

Read More +

Sign up foremail alerts

We'll keep you connected to the latest news about Achilles